Practice Based Nutrition Intervention-2
PBNI-2
1 other identifier
interventional
15
1 country
1
Brief Summary
This study aims to test hypotheses that are potentially important to diabetes management, with practical implications for reducing the medical, personal, and economic costs of the disease. Anticipated outcomes include reductions in glycosylated hemoglobin that are significantly greater than those achievable with current diet recommendations, reductions in medication use among many intervention-group participants, beneficial changes in body weight and serum lipid concentrations, and a demonstration of the acceptability of the intervention diet. Progress toward these goals could refine dietary guidance for individuals with diabetes, increase treatment expectations, and reduce the massive burden the disease currently imposes. The study further attempts to translate a dietary intervention studied in a clinical research setting to a medical practice. This will contribute to developing a model for diabetes care that can be used widely.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Jul 2014
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2012
CompletedFirst Posted
Study publicly available on registry
October 4, 2012
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedOctober 20, 2015
October 1, 2015
1 year
October 2, 2012
October 19, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hemoglobin A1C (diabetes management)
20 weeks
Secondary Outcomes (17)
Body Weight
20 Weeks
Blood Pressure
20 Weeks
Glucose
20 Weeks
Comprehensive Metabolic Panel
20 Weeks & one-year follow up
Serum cholesterol and triacylglycerol concentrations
20 Weeks
- +12 more secondary outcomes
Study Arms (2)
Vegan Group
EXPERIMENTALParticipants in the intervention group will follow a low-fat, vegan diet for 20 weeks, and will attend nutrition classes in the form of a weekly support group.
American Diabetes Association guidelines
ACTIVE COMPARATORParticipants will follow ADA diet according to ADA regulations. This group will also receive weekly nutrition classes.
Interventions
A diet devoid of any animal products. Low-fat, low-Glycemic Index, vegan diet.
Participants will follow individualized diet plans following ADA guidelines
Eligibility Criteria
You may qualify if:
- a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥126 mg/dl on 2 occasions or a prior physician's diagnosis of type 2 diabetes with the use of hypoglycemic medications for at least 6 months
- male or female
- A1c between 6.5% and 10.5%
- age at least 18 years
- ability and willingness to participate in all components of the study
- willingness to be assigned to either a low-fat, vegan diet or to standard care
- diabetes medications unchanged for 1 month prior to volunteering for the study
- patient of Dr. Mark Sklar
You may not qualify if:
- body mass index \>45 kg/m2
- alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
- pregnancy
- history of severe mental illness (with current unstable status)
- likely to be disruptive in group sessions (as determined by research staff)
- Signs/symptoms of acute uncontrolled diabetes (including but not limited to polyuria, polydipsia, blurred vision, uncontrolled weight loss)
- unstable medical status
- already following a low-fat, vegetarian diet
- an inordinate fear of blood draws
- inability to maintain current medication regimen
- lack of English fluency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Physicians Committee for Responsible Medicine
Washington D.C., District of Columbia, 20016, United States
Related Publications (3)
Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998 Dec 16;280(23):2001-7. doi: 10.1001/jama.280.23.2001.
PMID: 9863851BACKGROUNDEsselstyn CB Jr. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology). Am J Cardiol. 1999 Aug 1;84(3):339-41, A8. doi: 10.1016/s0002-9149(99)00290-8.
PMID: 10496449BACKGROUNDNicholson AS, Sklar M, Barnard ND, Gore S, Sullivan R, Browning S. Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med. 1999 Aug;29(2):87-91. doi: 10.1006/pmed.1999.0529.
PMID: 10446033BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neal Barnard, MD
Physicians Committee for Responsible Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2012
First Posted
October 4, 2012
Study Start
July 1, 2014
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
October 20, 2015
Record last verified: 2015-10